These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

547 related items for PubMed ID: 19768732

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification.
    Banin E, Dorrell MI, Aguilar E, Ritter MR, Aderman CM, Smith AC, Friedlander J, Friedlander M.
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):2125-34. PubMed ID: 16639024
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Herbimycin A inhibits angiogenic activity in endothelial cells and reduces neovascularization in a rat model of retinopathy of prematurity.
    McCollum GW, Rajaratnam VS, Bullard LE, Yang R, Penn JS.
    Exp Eye Res; 2004 May; 78(5):987-95. PubMed ID: 15051479
    [Abstract] [Full Text] [Related]

  • 26. Endostatin modulates VEGF-mediated barrier dysfunction in the retinal microvascular endothelium.
    Brankin B, Campbell M, Canning P, Gardiner TA, Stitt AW.
    Exp Eye Res; 2005 Jul; 81(1):22-31. PubMed ID: 15978251
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Increased expression of VEGF in retinal pigmented epithelial cells is not sufficient to cause choroidal neovascularization.
    Oshima Y, Oshima S, Nambu H, Kachi S, Hackett SF, Melia M, Kaleko M, Connelly S, Esumi N, Zack DJ, Campochiaro PA.
    J Cell Physiol; 2004 Dec; 201(3):393-400. PubMed ID: 15389527
    [Abstract] [Full Text] [Related]

  • 29. VEGF-induced choroidal damage in a murine model of retinal neovascularisation.
    Tee LB, Penrose MA, O'Shea JE, Lai CM, Rakoczy EP, Dunlop SA.
    Br J Ophthalmol; 2008 Jun; 92(6):832-8. PubMed ID: 18523088
    [Abstract] [Full Text] [Related]

  • 30. Development and pathology of the hyaloid, choroidal and retinal vasculature.
    Saint-Geniez M, D'Amore PA.
    Int J Dev Biol; 2004 Jun; 48(8-9):1045-58. PubMed ID: 15558494
    [Abstract] [Full Text] [Related]

  • 31. Increased expression of KDR/Flk-1 (VEGFR-2) in murine model of ischemia-induced retinal neovascularization.
    Suzuma K, Takagi H, Otani A, Suzuma I, Honda Y.
    Microvasc Res; 1998 Nov; 56(3):183-91. PubMed ID: 9828156
    [Abstract] [Full Text] [Related]

  • 32. Angiopoietin modulation of vascular endothelial growth factor: Effects on retinal endothelial cell permeability.
    Peters S, Cree IA, Alexander R, Turowski P, Ockrim Z, Patel J, Boyd SR, Joussen AM, Ziemssen F, Hykin PG, Moss SE.
    Cytokine; 2007 Nov; 40(2):144-50. PubMed ID: 17959386
    [Abstract] [Full Text] [Related]

  • 33. Variable oxygen and retinal VEGF levels: correlation with incidence and severity of pathology in a rat model of oxygen-induced retinopathy.
    Werdich XQ, McCollum GW, Rajaratnam VS, Penn JS.
    Exp Eye Res; 2004 Nov; 79(5):623-30. PubMed ID: 15500821
    [Abstract] [Full Text] [Related]

  • 34. Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors.
    Tobe T, Okamoto N, Vinores MA, Derevjanik NL, Vinores SA, Zack DJ, Campochiaro PA.
    Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):180-8. PubMed ID: 9430560
    [Abstract] [Full Text] [Related]

  • 35. Geldanamycin, a HSP90 inhibitor, attenuates the hypoxia-induced vascular endothelial growth factor expression in retinal pigment epithelium cells in vitro.
    Wu WC, Kao YH, Hu PS, Chen JH.
    Exp Eye Res; 2007 Nov; 85(5):721-31. PubMed ID: 17870069
    [Abstract] [Full Text] [Related]

  • 36. Decursin inhibits VEGF-mediated inner blood-retinal barrier breakdown by suppression of VEGFR-2 activation.
    Kim JH, Kim JH, Lee YM, Ahn EM, Kim KW, Yu YS.
    J Cereb Blood Flow Metab; 2009 Sep; 29(9):1559-67. PubMed ID: 19536074
    [Abstract] [Full Text] [Related]

  • 37. Anti-angiogenic effect of luteolin on retinal neovascularization via blockade of reactive oxygen species production.
    Park SW, Cho CS, Jun HO, Ryu NH, Kim JH, Yu YS, Kim JS, Kim JH.
    Invest Ophthalmol Vis Sci; 2012 Nov 19; 53(12):7718-26. PubMed ID: 23099493
    [Abstract] [Full Text] [Related]

  • 38. Müller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage.
    Wang J, Xu X, Elliott MH, Zhu M, Le YZ.
    Diabetes; 2010 Sep 19; 59(9):2297-305. PubMed ID: 20530741
    [Abstract] [Full Text] [Related]

  • 39. [Cell biology of intraocular vascular diseases].
    Ishibashi T.
    Nippon Ganka Gakkai Zasshi; 1999 Dec 19; 103(12):923-47. PubMed ID: 10643294
    [Abstract] [Full Text] [Related]

  • 40. Different effects of angiopoietin-2 in different vascular beds: new vessels are most sensitive.
    Oshima Y, Oshima S, Nambu H, Kachi S, Takahashi K, Umeda N, Shen J, Dong A, Apte RS, Duh E, Hackett SF, Okoye G, Ishibashi K, Handa J, Melia M, Wiegand S, Yancopoulos G, Zack DJ, Campochiaro PA.
    FASEB J; 2005 Jun 19; 19(8):963-5. PubMed ID: 15802489
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.